Related references
Note: Only part of the references are listed.Microbiota-Gut-Brain Axis: New Therapeutic Opportunities
Caitriona Long-Smith et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
α-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients
Sireesha Manne et al.
MOVEMENT DISORDERS (2020)
The gut in Parkinson's disease: Bottom-up, top-down, or neither?
Laurene Leclair-Visonneau et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2020)
Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease
Tobias Hegelmaier et al.
CELLS (2020)
A gut bacterial amyloid promotes α-synuclein aggregation and motor impairment in mice
Timothy R. Sampson et al.
ELIFE (2020)
Cerium Oxide Nanoparticles Rescue α-Synuclein-Induced Toxicity in a Yeast Model of Parkinson's Disease
Roberta Ruotolo et al.
NANOMATERIALS (2020)
Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells
Souvarish Sarkar et al.
FRONTIERS IN IMMUNOLOGY (2020)
Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease
Subrat K. Bhattamisra et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson's disease
Julien Bryois et al.
NATURE GENETICS (2020)
Immunotherapy for Parkinson's disease
Aaron D. Schwab et al.
NEUROBIOLOGY OF DISEASE (2020)
Alpha-SynucleinOligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies
Wolfgang Singer et al.
ANNALS OF NEUROLOGY (2020)
Enzyme Immunoassay-Based Platform for Accurate Detection of Serum Pathological α-Synuclein in Parkinson's Disease Patients
Benjamin W. Schlichtmann et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Gold nanoclusters for Parkinson's disease treatment
Guanbin Gao et al.
BIOMATERIALS (2019)
Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein
Dilshan S. Harischandra et al.
SCIENCE SIGNALING (2019)
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054
Miroslaw Brys et al.
MOVEMENT DISORDERS (2019)
Alpha-synuclein as therapeutic target in Parkinson’s disease
Franziska Richter Assêncio
Neuroforum (2019)
The multiple roles of exosomes in Parkinson's disease: an overview
Chiara Porro et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2019)
Cerium oxide NPs mitigate the amyloid formation of α-synuclein and associated cytotoxicity
Zahra Zand et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy
Chiara Maria Giulia De Luca et al.
TRANSLATIONAL NEURODEGENERATION (2019)
Prospective treatment of Parkinson's disease by a siRNA-LDH nanoconjugate
Rituparna Acharya et al.
MEDCHEMCOMM (2019)
Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease
Shengnan Tang et al.
DRUG DELIVERY (2019)
Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies
Edward Rockenstein et al.
JOURNAL OF NEUROSCIENCE (2018)
Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes
Souvarish Sarkar et al.
NEUROTOXICOLOGY (2018)
Localized delivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-targeted microbubble destruction for improved Parkinson's disease therapy
Nisi Zhang et al.
THERANOSTICS (2018)
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-a-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease A Randomized Clinical Trial
Joseph Jankovic et al.
JAMA NEUROLOGY (2018)
The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson's Disease
Farhang Aliakbari et al.
NANOSCALE (2018)
Ligand-cascading nano-delivery devices to enable multiscale targeting of anti-neurodegenerative therapeutics
Adam S. Mullis et al.
BIOMEDICAL MATERIALS (2018)
Cell-addictive dual-target traceable nanodrug for Parkinson's disease treatment via flotillins pathway
YanHui Li et al.
THERANOSTICS (2018)
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Fakhar Ud Din et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Anionic liposomes for small interfering ribonucleic acid (siRNA) delivery to primary neuronal cells: Evaluation of alpha-synuclein knockdown efficacy
Michele Schlich et al.
NANO RESEARCH (2017)
Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis
Benjamin J. Andreone et al.
NEURON (2017)
Gut microbiota: Implications in Parkinson's disease
Arun Parashar et al.
PARKINSONISM & RELATED DISORDERS (2017)
Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson's Disease
Christin Helmschrodt et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson's Disease
Paromita Kundu et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases
Mathieu Bourdenx et al.
AUTOPHAGY (2016)
Curcumin-Loaded Amine-Functionalized Mesoporous Silica Nanoparticles Inhibit α-Synuclein Fibrillation and Reduce Its Cytotoxicity-Associated Effects
Nayere Taebnia et al.
LANGMUIR (2016)
Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease
Richard Gordon et al.
NEUROBIOLOGY OF DISEASE (2016)
Alpha-Synuclein Oligomers-Neurotoxic Moleculesin Parkinson's Disease and Other Lewy Body Disorders
Martin Ingelsson
FRONTIERS IN NEUROSCIENCE (2016)
The endosomal pathway in Parkinson's disease
Rebecca M. Perrett et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2015)
Implications of glial nitric oxide in neurodegenerative diseases
Jose Enrique Yuste et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Small molecule-mediated stabilization of vesicle-associated helical α-synuclein inhibits pathogenic misfolding and aggregation
Luis Fonseca-Ornelas et al.
NATURE COMMUNICATIONS (2014)
What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?
Dana Kim et al.
Experimental Neurobiology (2014)
Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
H Braak et al.
NEUROSCIENCE LETTERS (2006)
Share Paper
